BP435

ナプロキセン

British Pharmacopoeia (BP) Reference Standard

• 別名: (S)-(+)-2-(6-メトキシ-2-ナフチル)プロピオン酸, (S)-(+)-6-メトキシ-α-メチル-2-ナフタレン酢酸
• 化学式: CH₃OC₁₀H₆CH(CH₃)CO₂H
• CAS番号: 22204-53-1
• 分子量: 230.26
• Beilstein: 3591068
• EC Number: 244-838-7
• MDL番号: MFCD00010500
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: naproxen
• 形状: powder
• シェルフライフ: limited shelf life, expiry date on the label
• メーカー／製品名: BP
• mp: 152-154 °C (lit.)
• アプリケーション: pharmaceutical; pharmaceutical small molecule
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O
• InChI: 1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
• InChI Key: CMWTZPSULFXXJA-VIFPVBQESA-N
• 遺伝子情報: human ... PTGS1(5742) , PTGS2(5743)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Naproxen BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Naproxen Gastro-resistant Tablets

Naproxen Oral Suspension

Naproxen Tablets

生物化学的／生理学的作用

非選択的なシクロオキシゲナーゼ(COX-1およびCOX-2)阻害剤です。

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS07,GHS09
• シグナルワード: Warning
• 危険有害性情報: H302,H315,H319,H335,H361fd,H411
• 注意書き: P202 - P273 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• 危険有害性の分類: Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT SE 3
• ターゲットの組織: Respiratory system
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3